Preliminary safety and anti-tumor activity of TYRA-300, a highly selective FGFR3 inhibitor, in participants with advanced solid tumors with activating FGFR3 mutations/fusions (SURF301) Meeting Abstract
| Authors: | Tran, B.; Boni, A.; Hansen, A.; Boni, V.; Mantia, C.; Yu, E.; Weickhardt, A.; Robert, M.; Gupta, S.; Necchi, A.; Morales-Barrera, R.; Hoimes, C.; Berlin, J.; Iyer, G.; Millward, M.; Burn, T.; Lihou, C.; Gammon, G.; Rosenberg, J.; Loriot, Y. |
| Abstract Title: | Preliminary safety and anti-tumor activity of TYRA-300, a highly selective FGFR3 inhibitor, in participants with advanced solid tumors with activating FGFR3 mutations/fusions (SURF301) |
| Meeting Title: | 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 211 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Oct 23-25 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | S175 |
| Language: | English |
| ACCESSION: | WOS:001345547300450 |
| DOI: | 10.1016/j.ejca.2024.114978 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 500LBA LBA Orals -- Article number: 114978 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work